Cassava Sciences Inc [NASDAQ: SAVA] stock went on an upward path that rose over 19.79% on Thursday, amounting to a one-week price increase of more than 9.11%.
Over the last 12 months, SAVA stock rose by 61.77%. The one-year Cassava Sciences Inc stock forecast points to a potential upside of 68.8. The average equity rating for SAVA stock is currently 2.33, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $1.36 billion, with 47.98 million shares outstanding and 44.98 million shares in the current float. Compared to the average trading volume of 3.06M shares, SAVA stock reached a trading volume of 3752968 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Cassava Sciences Inc [SAVA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SAVA shares is $91.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SAVA stock is a recommendation set at 2.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Cassava Sciences Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 01, 2024. The new note on the price target was released on November 16, 2022, representing the official price target for Cassava Sciences Inc stock. Previously, the target price had yet another raise to $100, while Cantor Fitzgerald analysts kept a Neutral rating on SAVA stock. On July 07, 2021, analysts increased their price target for SAVA shares from 80 to 190.
The Average True Range (ATR) for Cassava Sciences Inc is set at 4.25 The Price to Book ratio for the last quarter was 7.21, with the Price to Cash per share for the same quarter was set at 4.32.
SAVA Stock Performance Analysis:
Cassava Sciences Inc [SAVA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.11. With this latest performance, SAVA shares gained by 196.66% in over the last four-week period, additionally plugging by 17.80% over the last 6 months – not to mention a rise of 61.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SAVA stock in for the last two-week period is set at 62.33, with the RSI for the last a single of trading hit 63.48, and the three-weeks RSI is set at 60.95 for Cassava Sciences Inc [SAVA]. The present Moving Average for the last 50 days of trading for this stock 17.94, while it was recorded at 23.97 for the last single week of trading, and 21.50 for the last 200 days.
Insight into Cassava Sciences Inc Fundamentals:
Cassava Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.07 and a Current Ratio set at 4.07.
SAVA Stock EPS
With the latest financial reports released by the company, Cassava Sciences Inc posted -0.61/share EPS, while the average EPS was predicted by analysts to be reported at -0.77/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.16. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SAVA.
Cassava Sciences Inc [SAVA] Institutonal Ownership Details
The top three institutional holders of SAVA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in SAVA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in SAVA stock with ownership which is approximately 5.1238%.
